Stock comparison
TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.49 B vs $2.32 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
TMDX is larger
TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.49 B vs $2.32 B).
Market value leader
TMDX
TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.49 B vs $2.32 B).
Revenue leader
TMDX
AXGN: $225.21M vs TMDX: $605.49M.
Profit leader
TMDX
AXGN: -$15.70M vs TMDX: $190.30M.
Margin leader
TMDX
AXGN: -7.0% vs TMDX: 31.4% net margin.
| Metric | AXGN | TMDX |
|---|---|---|
| Market cap | $2.32 B | $2.49 B |
| US-listed rank | #2028 | #1983 |
| Revenue (latest FY) | $225.21M | $605.49M |
| Net income (latest FY) | -$15.70M | $190.30M |
| Net margin | -7.0% | 31.4% |
| P/E (trailing FY) | - | 13.1x |
| SEC filings | 1,334 | 615 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
TransMedics Group, Inc. is 1.1x more valuable than Axogen, Inc. by market capitalization ($2.49 B vs $2.32 B).
In their latest fiscal years, Axogen, Inc. reported $225.21M in revenue while TransMedics Group, Inc. reported $605.49M.
Full pages: Axogen, Inc. and TransMedics Group, Inc., or browse the full rankings.